Braveheart, Attovia, Apnimed Announce July IPO Plans
Biotech companies Braveheart (BRVE), Attovia Therapeutics (ATTO), and Apnimed have announced their intentions to go public in July. This follows a trend of increased initial public offerings among biotechnology firms.
Topics: biotech IPOs public offerings